TR201703079A2 - THE USE OF A VEGETABLE FORMULATION CONTAINING PUMPKIN SEED OIL IN THE TREATMENT OF BPH - Google Patents
THE USE OF A VEGETABLE FORMULATION CONTAINING PUMPKIN SEED OIL IN THE TREATMENT OF BPH Download PDFInfo
- Publication number
- TR201703079A2 TR201703079A2 TR2017/03079A TR201703079A TR201703079A2 TR 201703079 A2 TR201703079 A2 TR 201703079A2 TR 2017/03079 A TR2017/03079 A TR 2017/03079A TR 201703079 A TR201703079 A TR 201703079A TR 201703079 A2 TR201703079 A2 TR 201703079A2
- Authority
- TR
- Turkey
- Prior art keywords
- seed oil
- pumpkin seed
- treatment
- capsule
- bph
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
İlaç sektöründe; özellikle esansiyel yağ asitleri içeriği açısından zengin kabak tohumu yağı ile hazırlanan; antioksidan özelliğe sahip yumuşak kapsül halindeki bir bitkisel formülasyonun BPH (Benign Prostat Hiperplazisi/ İyi huylu prostat büyümesi) tedavisinde kullanımı ile ilgilidir. Bahsedilen bitkisel formülasyon, kabak tohumu yağı, dl in bütünlüğünü ve kapsül oluşumunu sağlayan jelatin içermektedir.In the pharmaceutical industry; prepared with pumpkin seed oil, especially rich in essential fatty acids; It is about the use of a herbal formulation in soft capsule form with antioxidant properties in the treatment of BPH (Benign Prostate Hyperplasia / Benign prostatic enlargement). Said herbal formulation contains pumpkin seed oil, gelatin which provides the integrity of dl and capsule formation.
Description
TEKNIK ALAN Bu bulus, kimya sektöründe, ilaç endüstrisinde kabak tohumu yagi (Oleum Cucurbitae semen) içeren bir bitkisel formülasyonun kullanimi ile ilgilidir. TECHNICAL FIELD This invention is used in the chemical industry, pharmaceutical industry, pumpkin seed oil (Oleum Cucurbitae). relates to the use of an herbal formulation containing semen.
Bulus özellikle esansiyel yag asitleri içerigi açisindan zengin kabak tohumu yagi ile hazirlanan; antioksidan özellige sahip yumusak kapsül halindeki bir bitkisel formülasyonun BPH (Benign Prostat Hiperplazisi/ Iyi huylu prostat büyümesi) tedavisinde kullanimi ile TEKNIGIN BILINEN DURUMU Esansiyel yag asitleri; organizmanin yasamini devam ettirebilmesi için disardan alinmasi gereken, vücutta sentezlenemeyen yag asitleridir. Bu esansiyel yag asitleri besinler yoluyla veya bazi takviyeler ile organizmaya alinmalidir. Disaridan organizmaya alinan esansiyel yag asitleri BPH (Benign Prostat Hiperplazisi/ Iyi huylu prostat büyümesi) tedavisine yardimci olarak görev almaktadirlar. The invention is especially combined with pumpkin seed oil, which is rich in essential fatty acids. prepared; of a herbal formulation in soft capsule form with antioxidant properties. With its use in the treatment of BPH (Benign Prostatic Hyperplasia / Benign Prostatic Enlargement) KNOWN STATE OF THE TECHNIQUE essential fatty acids; removal of the organism from outside in order to continue its life What is needed are fatty acids that cannot be synthesized in the body. These essential fatty acids are obtained through food. or it should be taken into the organism with some supplements. Essential substance taken from the outside into the organism Fatty acids help treat BPH (Benign Prostatic Hyperplasia / Benign Prostatic Enlargement) are working as.
Mevcut teknikte; BPH (Benign Prostat Hiperplazisi/ Iyi huylu prostat büyümesi) tedavisine yardimci olarak kullanilan ürünlerde sentetik madde veya belli oranlarda kimyasal madde bulunmaktadir. Sentetik ve kimyasal maddelerin kullanimi organizmada birçok yan etkilere neden olarak vücudun birçok sistemini kötü yönde etkilemektedir. In the current technique; BPH (Benign Prostatic Hyperplasia / Benign Prostatic Enlargement) treatment Synthetic substance or chemical substance in certain proportions in products used as auxiliary are available. The use of synthetic and chemical substances has many side effects in the organism. As a result, it affects many systems of the body in a bad way.
Ayrica mevcut uygulamalarin birçogunda ürünler sivi formda bulunmaktadir. Bu durum kontrollü dozlamanin yapilmasini güçlestirmektedir. Bu nedenle gerekli doz, tam ve net olarak saglanamamaktadir. Also, in many of the current applications, the products are available in liquid form. This situation makes controlled dosing difficult. Therefore, the required dose is complete and clear. cannot be provided.
Literatürde konu ile ilgili yer alan patentlerden biri CN105981810 numarali basvurudur. One of the patents on the subject in the literature is the application numbered CN105981810.
Mevcut bulus; kabak çekirdegi özünün yani sira birçok bitkisel ürün, su ve yüksek oranda süt karisimindan elde edilen tansiyon düzenleyici, böbrek ve dalak canlandirici, kabizlik tedavisine yardimci ve yaslanmayi geciktirici mayali yogurttan bahsetmektedir. The present invention; pumpkin seed extract, as well as many herbal products, water and a high percentage of milk blood pressure regulator, kidney and spleen revitalizer, constipation He mentions fermented yogurt, which helps treatment and delays aging.
Mevcut teknikte yer alan diger bir CN102908544 numarali basvuru ise içerisinde kabak tohumunun da bulundugu oransal olarak birçok bitkisel malzemenin karistirilarak olusturuldugu kalp sagligina iyi gelen bir formülasyondan ve bu formülasyonun kaynatilarak hazirlama tekniginden bahsetmektedir. Another application numbered CN102908544 in the current technique is pumpkin. By mixing many herbal materials proportionally, including the seeds, It is made from a formulation that is good for heart health and by boiling this formulation. It talks about the preparation technique.
Sonuç olarak yukarida anlatilan olumsuzluklardan dolayi ve mevcut çözümlerin konu hakkindaki yetersizligi nedeniyle kabak tohumu yaginin BPH (Benign Prostat Hiperplazisi/ Iyi huylu prostat büyümesi) ile ilgili teknik alanda bir gelistirme yapilmasi gerekli kilinmistir. As a result, due to the above-mentioned negativities and existing solutions Due to its inadequacy about BPH (Benign Prostatic Hyperplasia / Good It has been deemed necessary to make a development in the technical field related to benign prostatic enlargement.
BULUSUN AMACI Bulusun ana amaci kabak tohumu yagi (Oleum Cucurbitae semen) içeren bir bitkisel formülasyonun, BPH (Benign Prostat Hiperplazisi/ Iyi huylu prostat büyümesi) tedavisine yardimci olarak kullaniminin saglanmasidir. Kabak tohumu yagi 5-0i redüktaz enzim inhibisyonunu yapar. Bu sayede testosteronun, dihidrotestosterona (DHT) dönüsümünü engelleyerek prostat bezi ile ilgili hastaliklarda tedaviye yardimci oldugu bildirilmistir. OBJECTIVE OF THE INVENTION The main object of the invention is to produce a vegetable oil containing pumpkin seed oil (Oleum Cucurbitae semen). formulation for the treatment of BPH (Benign Prostatic Hyperplasia / Benign Prostatic Enlargement) its use as an aid. Pumpkin seed oil 5-0i reductase enzyme does its inhibition. In this way, the conversion of testosterone to dihydrotestosterone (DHT) It has been reported that it helps the treatment of diseases related to the prostate gland by preventing it.
Kabak tohumu yagi nitrik oksit üzerinden mesane doldugunda mesane kaslarini gevseterek inkontinansi engellemektedir. Pelvik kaslar ve nitrik oksit üzerine olan bu ikili etkilerine bagli olarak kabak tohumu yagi inkontinansi azaltmaktadir. Kabak tohumu yagi, özellikle sistit gibi idrar yolu enfeksiyonlarinda da tedaviye yardimci olarak kullanilabilmektedir. Pumpkin seed oil relaxes the bladder muscles when the bladder is filled with nitric oxide. prevents incontinence. Due to these dual effects on the pelvic muscles and nitric oxide As a result, pumpkin seed oil reduces incontinence. Pumpkin seed oil, especially like cystitis It can also be used as an aid in the treatment of urinary tract infections.
Bu bulusun diger bir amaci, olusturulan formülasyonun, hiçbir kimyasal madde içermeden, kabak tohumu yaginin elde edilmesinde dahi herhangi bir isil yada kimyasal islem uygulanmamaktadir. Böylece; bitkinin içerisindeki etken maddeler, besin degerleri, vitamin ve mineraller kaybolmadan direkt ürüne geçmektedir. Another aim of this invention is that the formulation formed does not contain any chemicals, Even in the production of pumpkin seed oil, any heat or chemical treatment not applicable. Like this; active ingredients, nutritional values, vitamins and minerals pass directly to the product without being lost.
Bu bulusun bir diger amaci kimyasal olmadan olusturulan içerik sayesinde insan sagligini kötü yönde etkileyecek yan etkilerin minimuma indirilmesinin saglanmasidir. Tamamen dogal ve bitkisel ürün kullanimiyla çok nadir olarak bulanti, kusma, ishal gibi sadece mide-bagirsak sistemini etkileyen yan etkiler gözlenmektedir. Another aim of this invention is to protect human health thanks to the content created without chemicals. It is to ensure that the side effects that will adversely affect are minimized. completely natural and very rarely with the use of herbal products, such as nausea, vomiting, diarrhea, only gastro-intestinal side effects affecting the system are observed.
Bu bulusun diger bir amaci, olusturulan formülasyonun kapsül formunda olmasiyla, hasta kompliyansi ve hasta uyuncu açisindan kullanim kolayliginin saglanmasidir. Ayrica, olusturulan kapsül formu sayesinde bahsedilen endikasyonlarda dozlamayi elde etmede avantaj saglanmaktadir. Another object of this invention is that the formulation formed is in capsule form, so that the patient It is to provide ease of use in terms of compliance and patient compliance. Moreover, in obtaining the dosing in the mentioned indications thanks to the capsule form created. advantage is provided.
BULUSUN DETAYLI AÇIKLAMASI Bu bulusun amacina ulasmasi için gerçeklestirilen kabak tohumu yagi kullanilarak elde edilmis bitkisel bir kapsül formülasyonun tercih edilen kullanimi sadece konunun daha iyi anlasilmasina yönelik olarak ve hiçbir sinirlayici etki olusturmayacak sekilde açiklanmaktadir. DETAILED DESCRIPTION OF THE INVENTION In order to achieve the aim of this invention, it is obtained by using pumpkin seed oil. The preferred use of an herbal capsule formulation that has been for understanding and without any limiting effect is explained.
Kabak Tohumu Yagi: Kabak tohumu yagi bitkisel tibbi ürün olarak yüzyillardir kullanilmaktadir. Kabak tohumu yagi bilesimindeki maddelerin çok çesitli olmasi ve her birinin terapötik etkinliklerinin farkli olmasi nedeniyle pek çok farkli farmakolojik etki göstermektedir. Pumpkin Seed Oil: Pumpkin seed oil has been used as a herbal medicinal product for centuries. Pumpkin seed oil The fact that the substances in its composition are very diverse and the therapeutic activities of each are different. It has many different pharmacological effects.
Kabak tohumlari; fitosteroller, tokoferoller ve esansiyel yag asitleri içerigi açisindan zengindir (çogunlukla linoleik ve oleik asit) ve kabak tohumlarinin içerisindeki varsayilan aktif bilesenler A7-steroller (avenasterol ve spinasterol) ve A5-sterollerdir (sitosterol, stigmasterol). Kabak tohumu yagi 5-0i redüktaz enzim inhibisyonunu yapar. Bu sayede testosteronun, dihidrotestosterona (DHT) dönüsümünü engelleyerek prostat bezi ile ilgili hastaliklarda tedaviye yardimci oldugu bildirilmistir. Pumpkin seeds; rich in phytosterols, tocopherols and essential fatty acids content (mostly linoleic and oleic acid) and the assumed active ingredients in pumpkin seeds They are A7-sterols (avenasterol and spinasterol) and A5-sterols (sitosterol, stigmasterol). Pumpkin Seed oil inhibits 5-0i reductase enzyme. In this way, testosterone In diseases related to the prostate gland by preventing the conversion of dihydrotestosterone (DHT) It has been reported to be helpful in treatment.
Kabak tohumu yaginin benign prostat hiperplazisi üzerinde olan etkilerini arastirma amaciyla pek çok nonklinik ve klinik çalisma yapilmistir. Yapilan klinik çalismalarda kabak tohumu yaginin benign prostat hiperplazisi tedavisine yardimci ve klinik olarak güvenli bir sekilde uygulanabilecegi gösterilmistir. To investigate the effects of pumpkin seed oil on benign prostatic hyperplasia. Many nonclinical and clinical studies have been done. Pumpkin seeds in clinical studies essential oil is clinically safe and helpful in the treatment of benign prostatic hyperplasia. shown to be applicable.
Kabak tohumu yagi, antihelmintik (schistosomiasis, tenya vb.) tedaviye yardimci olarak uzun yillardan beri kullanilmaktadir. Yapilan bir klinik çalismada, primer olarak Asya ve Afrikalda salyangozlar araciligiyla yayilan ciddi bir paraziter hastalik olan Schistosomiasis için kabak çekirdeklerinin yardimci olabilecegi gösterilmistir. Ayrica yapilan çalismalarda kabak çekirdeklerinin, tenya tedavisinde yardimci olabilecegi bildirilmistir. Pumpkin seed oil has long been used as an adjunct to anthelmintic (schistosomiasis, tapeworm, etc.) treatment. has been used for years. In a clinical study, primarily in Asia and Africa, Zucchini for Schistosomiasis, a serious parasitic disease spread by snails kernels have been shown to be helpful. In the studies carried out, pumpkin seeds have been reported to be helpful in the treatment of tapeworm.
Kapsül formülasyon içerigL Formülasyonda, etken madde olarak kabak tohumu yagi, yardimci maddeler olarak ise dl oi- tokoferol, dI oi-tokoferil asetat, gliserin, saf su ve jelatin kullanilmaktadir. dl oi-tokoferol ve dI oi-tokoferil asetat koruyucu madde görevinde kullanilmaktadir. Söz konusu formülasyonda; dl oi-tokoferol, dl oi-tokoferil asetat, ppm düzeyinde katilmaktadir. Içerigin bütünlügünü saglamak üzere kullanilan jelatin için ise; sigir jelatini kullanilmaktadir. Jelatine alternatif olarak, hayvansal kaynakli ve bitkisel digerjelatinler kullanilabilir. Capsule formulation content In the formulation, pumpkin seed oil as active ingredient and dl oil as auxiliary substances tocopherol, di-tocopheryl acetate, glycerin, purified water and gelatin are used. dl oi-tocopherol and dI oi-tocopheryl acetate is used as a preservative. In the formulation in question; dl oi-tocopherol, dl oi-tocopheryl acetate are added at ppm level. the integrity of the content For the gelatin used to provide; bovine gelatin is used. Alternative to gelatin As an alternative, other gelatins of animal origin and vegetable origin can be used.
Tablo 1'de de belirtildigi üzere; içerikte agirlikça % 42,635 oraninda kabak tohumu yagi; Tablo 1. Kapsülün içerigi ve agirlikça yüzdeleri Tercih edilen Kullanilabilir agirlikça miktar (%) Kabak tohumu yagi 42,635 320 dl oi-tokoferol 0,0030 0,024 dl oi-tokoferil asetat 0,0213 0,160 Gliserin 10,723 80,5 Su 23,312 175 Jelatin 23,312 175 Kapsülün üretim yöntemi: Kapsül formülasyonun üretim basamaklari söyledir: Hammaddelerden bir tanesi olan, kabak tohumu, eleme isleminden geçirilmektedir. Eleme isleminin ardindan gerekirse kirma islemi gerçeklestirilmektedir. Kabak tohumu, söz konusu islemlerden geçirilip istenilen boyutun elde edilmesinin ardindan, soguk pres ünitesine gönderilmektedir. Soguk pres yöntemi ile hammaddeden yag çikarilmasi islemi gerçeklestirilmektedir. Söz konusu yöntemde 55 0Cinin üstüne çikilmamalidir. Soguk pres ünitesinden gelen yag, filtrasyon isleminden önce karistirma ve dinlendirme tanklarinda tutulmaktadir. Böylece olasi partiküllerin, karistirma ve dinlenme islemleriyle ayrilmasi kolaylasmaktadir. Çikarilan yag; karistirma ve dinlenme tanklarindan sonra, kapali ortamda ve oda sicakliginda filtre ünitesine beslenmektedir. Filtre ünitesinde, varsa yag içeriginde bulunan partküller filtre edilmektedir. Filtrasyon asamasindan sonra, elde edilen yaga; koruyucu madde olarak dl oi- tokoferol ve koruyucu madde olarak dI d-tokoferil asetat eklenmektedir. Böylece içerigi olusturan karisim elde edilmektedir. As stated in Table 1; pumpkin seed oil at a rate of 42,635% by weight; Table 1. Contents and weight percentages of the capsule Preferred by usable weight quantity (%) Pumpkin seed oil 42,635 320 dl oi-tocopherol 0.0030 0.024 dl oi-tocopheryl acetate 0.0213 0.160 Glycerin 10,723 80.5 water 23.312 175 Gelatin 23.312 175 Production method of the capsule: The production steps of the capsule formulation are as follows: Pumpkin, which is one of the raw materials The seed is passed through the screening process. After the sieving process, if necessary, the crushing process is carried out. Pumpkin seeds are passed through the aforementioned processes and the desired size is obtained. After being processed, it is sent to the cold press unit. With the cold press method The process of extracting oil from the raw material is carried out. In the said method, 55 0C should not be stepped on. The oil from the cold press unit is removed before the filtration process. are kept in mixing and settling tanks. Thus, possible particles, mixing and It is easier to leave with resting procedures. extracted oil; after mixing and resting tanks, indoors and at room temperature is fed to the filter unit. In the filter unit, the particles in the oil content, if any, are filtered. is being done. After the filtration step, the obtained oil; dl oi- as preservative tocopherol and dI d-tocopheryl acetate as preservative are added. Thus the content The resulting mixture is obtained.
Bu islemler gerçeklestirilirken diger taraftan; jelatin hazirlama ünitesinde, kapsül bütünlügünün saglanmasi için kullanilan jelatin hazirlanmaktadir. While these transactions are being carried out, on the other hand; in the gelatin preparation unit, the capsule The gelatin used to ensure its integrity is being prepared.
Karisimin olusturulmasi ve jelatinin hazirlanmasinin akabinde, kapsül üretim ünitesine gönderilerek istenilen dozajda kapsüller hazirlanmaktadir. Bahsedilen kapsül, yumusak jelatin kapsüldür. After the mixture is formed and the gelatine is prepared, it is sent to the capsule production unit. capsules are prepared in the desired dosage. Said capsule, soft gelatin capsule.
Kapsül hazirlandiktan sonra kurutma islemi gerçeklestirilmektedir. Kurutulmus kapsüller ambalajlanmaktadir. After the capsule is prepared, the drying process is carried out. dried capsules is being packaged.
Kapsülün Kullanim Talimati: Terapötik Endikasyonlari Kapsül, esansiyel (temel) yag asitleri içerigi açisindan zengindir. BPH (Benign Prostat Hiperplazisi) tedavisine yardimci olarak kullanilir. Capsule Usage Instructions: Therapeutic Indications The capsule is rich in essential (essential) fatty acids content. BPH (Benign Prostate It is used as an adjunct to the treatment of hyperplasia.
D_ozai ve Uvqulama Yöntemi . Dozaj uygulama sikligi ve süresi: Doktor tarafindan baska bir sekilde tavsiye edilmedigi yolla alinir. 0 Uygulama Yöntemi: Kapsüller agizda ezilmeden veya çignenmeden yeterli miktarda su ile tercihen tok karnina yutulmalidir. Özel Popülasyonlara Iliskin Ek Bilgiler: o Böbrek/karaciger yetmezligi: Böbrek ve karaciger hastalarinda yapilmis yeterli güvenlilik çalismasi olmadigindan bu hasta gruplarinda kullanilmamalidir. o Pediyatrik popülasyon: Kapsül, 18 yasin altindaki çocuklarda ve adolesanlarda doktor kontrolünde kullanilmalidir. o Geriatrik popülasyon: Yaslilarda yapilmis çalisma bulunmamaktadir. D_ozai and the UVqulama Method . Dosage frequency and duration of administration: Unless otherwise recommended by the doctor taken by way. 0 Method of Application: Sufficient amount of water without crushing or chewing the capsules in the mouth It should preferably be swallowed with a full stomach. Additional Information on Special Populations: o Kidney/liver failure: Adequate safety has been established in kidney and liver patients. Since there is no study, it should not be used in these patient groups. o Pediatric population: Capsule for children under 18 and adolescents should be used under control. o Geriatric population: There is no study in the elderly.
Kontrendikasyonlar - Etkin maddeye veya kapsülün herhangi bir bilesenine alerjisi olanlarda, - Gebelikte ve emzirme döneminde, - Karaciger ve böbrek yetmezligi olan hastalarda kullanilmamalidir. Contraindications - Those who are allergic to the active substance or any component of the capsule, - During pregnancy and lactation, - It should not be used in patients with liver and kidney failure.
Kullanim için Özel Uyarilar ve Önlemler Oral antikoagülan ilaç kullanan hastalarda kapsülün günlük dozunun 3 g'i asmamasi gerekmektedir. Special Warnings and Precautions for Use The daily dose of the capsule should not exceed 3 g in patients using oral anticoagulant drugs. required.
Her bir kapsülde 0,0805 g gliserin içermektedir. Ancak bu dozda gliserine bagli herhangi bir yan etki beklenmemektedir. Each capsule contains 0.0805 g of glycerin. However, at this dose, any glycerin-related No side effects are expected.
Kapsülün kullanimi sirasinda sikayetleriniz kötülesirse veya ates, spazm, idrarda kan, agrili idrar yapma ya da üriner retansiyon gibi semptomlar gözlenirse doktorunuza veya eczaciniza danisiniz. If your complaints get worse while using the capsule or if you have fever, spasm, blood in the urine, painful If symptoms such as urination or urinary retention are observed, tell your doctor or pharmacist. you consult.
Kapsülün 2 aydan daha uzun süreli kullaniminin doktora danisilarak sürdürülmesi önerilmektedir. Continuing the use of the capsule for more than 2 months in consultation with the doctor recommended.
Gebelik ve Laktasyon 0 Genel Tavsiye: Çocuk dogurma potansiyeli bulunan kadinlar/Dogum kontrolü konuyla ilgili herhangi bir çalisma bulunmadigindan kullanilmamalidir. 0 Gebelik dönemi: Kabak tohumu yagina gebeliklerde maruz kalmaya iliskin klinik veri mevcut degildir. Hayvanlar üzerinde yapilan çalismalar gebelik ve/veya embriyonel/fetal gelisim ve/veya dogum ve/veya dogum sonrasi gelisim üzerindeki etkiler bakimindan yetersizdir. Insanlara yönelik potansiyel risk bilinmemektedir. Oral kontraseptif ilaçlarla birlikte kullanimi ile ilgili yeterli bilgi mevcut degildir. Gebelikte güvenliligi gösterilmediginden kapsülün gebelikte kullanilmasi önerilmemektedir. o Laktasyon dönemi: Laktasyonda güvenliligi gösterilmediginden kapsülün laktasyonda kullanilmasi önerilmemektedir. Pregnancy and Lactation 0 General Advice: Women of childbearing potential/Contraception It should not be used as there is no related study. 0 Pregnancy: Clinical data on pregnancies exposure to pumpkin seed oil not available. Studies on animals have been associated with pregnancy and/or on embryonal/fetal development and/or birth and/or postnatal development insufficient in terms of effects. The potential risk for humans is unknown. Oral There is not enough information about its use with contraceptive drugs. in pregnancy The capsule is not recommended for use during pregnancy as its safety has not been demonstrated. o Lactation period: Since its safety has not been demonstrated in lactation, the capsule should not be used in lactation. use is not recommended.
. Gastrointestinal Hastaliklar: Yaygin bulanti, kusma, ishal. Bunlarin disinda günümüze kadar herhangi bir istenmeyen etki bildirilmemistir. . Gastrointestinal Disorders: Common nausea, vomiting, diarrhea. Apart from these to date No undesirable effects have been reported so far.
Doz Asimi Kabak tohumu yagi ile ilgili olarak günümüze kadar hiç doz asimi bildirilmemistir. Oral olarak kullanilan kabak tohumu yagi iyi tolere edilebilir, asiri doza bagli herhangi bir etki beklenmez. Overdose No overdose has been reported for pumpkin seed oil to date. orally Pumpkin seed oil used can be well tolerated, no effects due to overdose are expected.
Yine de asiri doz alimi sonrasi herhangi bir bulgu ortaya çikarsa tedavi semptomatik ve destekleyici olmalidir. Spesifik bir antidotu ve eliminasyonunu arttirici bir yöntem yoktur. However, if any signs occur after an overdose, treatment should be symptomatic and should be supportive. There is no specific antidote and no method to increase its elimination.
Saklama Kosullari Ürünün raf ömrü 2 yil olarak belirlenmistir. Storage Conditions The shelf life of the product is determined as 2 years.
Yukarida içerigi ve üretim yönteminden bahsedilen kapsül, Türkiye Cumhuriyeti Saglik Bakanligi otoritesince “Geleneksel Bitkisel Tibbi Ürün” olarak ruhsatlandirilmistir. Söz CUCURMIN adiyla 320 mg yumusak kapsül olarak geçmektedir. Yukarida sayilan endikasyonlara ve Geleneksel Bitkisel Tibbi Ürün Yönetmeligine göre Türkiye Cumhuriyeti Saglik Bakanligi tarafindan RUHSATLANDIRILMIS Geleneksel Bitkisel bir Tibbi Üründür. The capsule, the content and production method of which is mentioned above, is a product of the Republic of Turkey Health It has been licensed as a "Traditional Herbal Medicinal Product" by the Ministry of Health. Promise It is referred to as CUCURMIN as 320 mg soft capsules. listed above Republic of Turkey according to indications and Traditional Herbal Medicinal Product Regulation It is a Traditional Herbal Medicinal Product LICENSED by the Ministry of Health.
Piyasada belirtilen endikasyonlar için ruhsat almis, çok sayida sentetik kimyasal içeren ürün vardir. Fakat bu alanda saglik otoritelerince ruhsatlandirilmis böyle bir endikasyonu olan herhangi bir geleneksel bitkisel tibbi ürün bulunmamaktadir. Product containing many synthetic chemicals, licensed for indications specified in the market has. However, those who have such an indication licensed by the health authorities in this field There are no traditional herbal medicinal products.
Mevcut uygulamalarin çogunda; kötü hijyen kosullarinda üretim söz konusu iken ilgili formülasyon; Saglik Bakanliginin bir ilaç fabrikalarindan istedigi GMP (Good Manufacturing Practises) normlarinda üretimektedir. In most of the existing applications; when production is under poor hygienic conditions, formulation; The GMP (Good Manufacturing) required by the Ministry of Health from a pharmaceutical factory It produces in accordance with the Practises) norms.
Bilindigi üzere bitkisel ürünlerde standardizasyonu saglamak çok zor bir islemdir. Ilgili formülasyonun; o Tohumunda; pestisit, aflatoksin, agir metal ve etkin maddelerin analizi, mikrobiyolojik kontroller yapilmistir. As it is known, standardization in herbal products is a very difficult process. Relating to formulation; o In his seed; analysis of pesticides, aflatoxins, heavy metals and active substances, microbiological checks have been made.
. Soguk pres yagda; etkin maddelerin analizi için yöntem gelistirilmesi, validasyon ve mikrobiyolojik kontrolleri yapilmistir. 0 Tasarimda; hangi ürün?, hangi endikasyon?, hangi doz?, hangi dozaj formu? olacagi hesaplanmistir. . Ön formülasyonda; hangi etkin madde/hangi yardimci maddenin analizi? , hangi mikrobiyolojik kontroller?, hangi kalite kontrol parametreleri, hangi stabilite çalismalari yapilacagi düsünülüp, ona göre bir sistem gelistirilmistir. . In cold pressed oil; method development, validation and analysis for the analysis of active substances. microbiological controls were made. 0 In design; which product?, which indication?, which dose?, which dosage form? will be calculated. . In pre-formulation; analysis of which active substance/which excipient? , which microbiological controls?, which quality control parameters, which stability studies It was thought to be done and a system was developed accordingly.
. Stabilite çalismalarinda; ön görülen raf ömrü süresince belirlenen spesifikasyonlarina uygunlugunu kanitlayan stabilite çalismalari kanitlanmis olup; 25°C±2, % 60 ±5 nemde 24 aylik çalisma ve 40°C±2, % 75 ±5 nemde 6 aylik çalisma yapilmistir. Analitik test yöntemlerine iliskin validasyonlar ve datalari ve ambalaj spesifikasyonlari, etkilesimleri, analiz ve kontrol yöntemleri belirlenmistir. o Kapsül bazi ve iç materyallerinin hazirlanmasinda, içerik tayini (yag bilesenleri analizi), bazi vizkozite ve optik görünüs kontrolü vb. testler yapilmistir. 0 Üretim prosedüründe; kalitatif ve kantitatif içerik tayini, optik kontrol gibi in-proses kontroller ve içerik tayinleri, mikrobiyolojik analizler, optik kontrol gibi kalite kontrol prosedürleri uygulanmistir. Ayrica aktif bilesenin ve ürün örneginin HPLC analizleri yapilmis ve yag asit kompozisyonlari hesaplanmistir. Ayrica aktif maddenin kalibrasyon tablolari çikartilmistir. . In stability studies; to the specifications determined during the anticipated shelf life. stability studies proving its suitability have been proven; At 25°C±2, 60% ±5 humidity 24 months of operation and 6 months of operation at 40°C ± 2, 75% ± 5% humidity. analytical testing validations and data on methods and packaging specifications, interactions, analysis and control methods have been determined. o Content determination (oil component analysis) in the preparation of capsule base and internal materials, some viscosity and optical appearance control etc. tests have been done. 0 In the production procedure; in-process such as qualitative and quantitative content determination, optical control quality control such as controls and content determinations, microbiological analysis, optical control procedures have been applied. In addition, HPLC analyzes of active ingredient and product sample and fatty acid compositions were calculated. In addition, the calibration of the active substance tables are removed.
Yukarida anlatilan islemler; bitkisel ürünlerin standardizasyonu açisindan çok önemli detaylardir ve bu üründe ayrintili olarak yapilmistir. Bu ürün Saglik Bakanligi gibi bir saglik otoritesince Geleneksel Bitkisel Tibbi bir ürünün farmakodinamik özellikleri ruhsatlanarak, onay almistir. Bu ürün Saglik Bakanligi gibi bir saglik otoritesince Geleneksel Bitkisel Tibbi bir ürünün KÜB'ü (Kisa Ürün Bilgisi -Prospektüsü) ve KT'si (Kullanma Talimati) ruhsatlanarak, onay almistir. Bu ürün Saglik Bakanligi gibi bir saglik otoritesince Geleneksel Bitkisel Tibbi bir ürünün kullanim sekli ve dozu standart hale getirilip ruhsatlandirilarak, onay almistir. Bu anlamda Saglik Bakanligi ruhsatli geleneksel bitkisel tibbi bir ürünün klinik çalismalara uygun bir sekilde dozlamasi yazili hale getirilip saglik otoritelerince onaylatilip resmiyet kazandirilmis ve dünya tibbinin hizmetine sunulmustur. The operations described above; very important for the standardization of herbal products are details and have been made in detail in this product. This product is approved by the Ministry of Health. By licensing the pharmacodynamic properties of a Traditional Herbal Medicinal product by the authority, has been approved. This product is approved by a health authority such as the Ministry of Health for Traditional Herbal Medicine. SPC (Short Product Information-Placebook) and KT (Instruction for Use) of a product licensed and approved. This product is approved by a health authority such as the Ministry of Health. The way of use and dosage of a herbal medicinal product is standardized and licensed, and approval is obtained. has received. In this sense, the clinical practice of a traditional herbal medicinal product licensed by the Ministry of Health. Dosing in accordance with the studies is written and approved by the health authorities. It was made official and presented to the service of world medicine.
Claims (4)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/03079A TR201703079A2 (en) | 2017-02-28 | 2017-02-28 | THE USE OF A VEGETABLE FORMULATION CONTAINING PUMPKIN SEED OIL IN THE TREATMENT OF BPH |
| PCT/TR2018/050068 WO2018222164A2 (en) | 2017-02-28 | 2018-02-26 | Use of an herbal formula containing pumpkin seed oil in bph treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/03079A TR201703079A2 (en) | 2017-02-28 | 2017-02-28 | THE USE OF A VEGETABLE FORMULATION CONTAINING PUMPKIN SEED OIL IN THE TREATMENT OF BPH |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201703079A2 true TR201703079A2 (en) | 2017-07-21 |
Family
ID=64455729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/03079A TR201703079A2 (en) | 2017-02-28 | 2017-02-28 | THE USE OF A VEGETABLE FORMULATION CONTAINING PUMPKIN SEED OIL IN THE TREATMENT OF BPH |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201703079A2 (en) |
| WO (1) | WO2018222164A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109528806B (en) * | 2018-12-19 | 2021-08-06 | 刘东波 | Sterol composition in pumpkin seed oil and its application and medicine for treating benign prostatic hyperplasia |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000290192A (en) * | 1999-04-05 | 2000-10-17 | Hide Tatsuzaki | Therapeutic agent for dysuria |
| US20080031940A1 (en) * | 2006-08-02 | 2008-02-07 | Al Rodriguez | Quercetin-containing composition, methods of making, and methods of using |
| GB0712972D0 (en) * | 2007-07-04 | 2007-08-15 | Glaxosmithkline Consumer Healt | Formulation |
| JP3164015U (en) * | 2010-08-28 | 2010-11-11 | アサマ化成株式会社 | Tea bag containing pumpkin seeds |
| CN104189695A (en) * | 2014-09-17 | 2014-12-10 | 兰成然 | Chinese herbal medicine preparation for treating uroclepsia and preparation method thereof |
-
2017
- 2017-02-28 TR TR2017/03079A patent/TR201703079A2/en unknown
-
2018
- 2018-02-26 WO PCT/TR2018/050068 patent/WO2018222164A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018222164A3 (en) | 2019-04-04 |
| WO2018222164A9 (en) | 2019-05-02 |
| WO2018222164A2 (en) | 2018-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Braun et al. | Herbs and natural supplements, volume 2: An evidence-based guide | |
| JP2006503844A (en) | Compositions containing Panaxginseng and Pauliniacupana extracts | |
| WO2020044123A1 (en) | Therapeutic combinations of boswellia extract and cannabinoids | |
| Daud et al. | Development of Zingiber officinale in oral dissolving films: Effect of polymers on in vitro, in vivo parameters and clinical efficacy | |
| CN101890032A (en) | Antidepressant drug composition and preparation method of Rg1, Rb1, glycyrrhizic acid prescription | |
| TR201703079A2 (en) | THE USE OF A VEGETABLE FORMULATION CONTAINING PUMPKIN SEED OIL IN THE TREATMENT OF BPH | |
| Paul et al. | Review on medicated chocolate takes a patient-centered approach to drug delivery | |
| Saini et al. | Qualitative and quantitative assessment of four marketed formulations of Brahmi | |
| Winata et al. | A NARRATIVE REVIEW OF KNOWN PLANTS WHICH HAVE POTENTIAL BENEFITS AS NATURAL GALACTAGOGUES IN INDONESIA. | |
| TR201703084A2 (en) | THE USAGE OF A VEGETABLE FORMULATION CONTAINING PUMPKIN SEED OIL IN THE TREATMENT OF THE EXTREMELY ACTIVE BLADDER AND URINARY INCONTINENCE RELATED LOWER URINARY SYSTEM SYMPTOMS | |
| RU2517217C1 (en) | Agent for preventing chronic fatigue syndrome in males | |
| TWI587861B (en) | A pharmaceutical composition for increasing the content and availability of cyclic cyclic adenosine monophosphate and a method for producing the same | |
| BR102022006625A2 (en) | FOOD SUPPLEMENT AND ITS USE | |
| Mahale et al. | Design and evaluation of cost-effective oro-dispersible tablets of venlafaxine hydrochloride by effervescent method | |
| ES2488191T3 (en) | Pharmaceutical composition containing an extract of Serenoa repens | |
| Bilal et al. | Development of herbal formulation of medicinal plants and determination of its antihyperuricemic potential in vitro and in vivo rat's model. | |
| CN106038581A (en) | Medicinal composition for increasing content and utilization rate of cyclic adenosine monophosphate in vivo and preparation method thereof | |
| CN117883379A (en) | Oral alkaline solvent composition and preparation method and application thereof | |
| TR201705831A2 (en) | THE USE OF A VEGETABLE FORMULATION CONTAINING POMEGRANOUS SEED OIL TO REDUCE BLOOD FATS KNOWN AS TRIGLYCERITE | |
| RU2414231C1 (en) | Antioxidant | |
| CA3097836A1 (en) | Compositions for treating female sexual dysfunction | |
| TR201704362A2 (en) | THE USE OF A HERBAL FORMULATION CONTAINING LINEN SEED OIL IN THE TREATMENT OF CHRONIC CONSTIPATION | |
| TR201704364A2 (en) | THE USE OF A HERBAL FORMULATION CONTAINING LINEN SEED OIL IN THE TREATMENT OF LIGHT GASTROINTESTINAL DISEASES | |
| CN117414364A (en) | Anti-aging composition and related applications | |
| TR201703736A2 (en) | THE USE OF A VEGETABLE FORMULATION CONTAINING LINEN SEED OIL IN THE TREATMENT OF HEART Vascular SYSTEM DISEASES |